Alibaba Health Information Technology (0241.HK) Financial Analysis & Valuation | Quarter Chart
Alibaba Health Information Technology (0241.HK)
0241.HKPrice: $0.64
Fair Value: 🔒
🔒score
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs,... more
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmac... more
Description
Shares
| Market Cap | $10.34B | Exchange | HKSE |
| Sector | Healthcare | Industry | Medical - Pharmaceuticals |
| Country | HK | CEO | Difan Shen |
| IPO Date | 1972-07-06 | CAGR | 0.28% |
| Employees | 1,422 | Website | www.alihealth.cn |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.86% | Total Yield | 2.86% |
0241.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $66.66B | P/E Ratio | 38.62 |
| Forward P/E | 26.13 | PEG Ratio | 0.52 |
| P/S Ratio | 0.02 | P/B Ratio | 0.02 |
| P/CF Ratio | 0.33 | P/FCF Ratio | 0.32 |
| EPS | $0.02 | EPS Growth 1Y | -15.67% |
| EPS Growth 3Y | 318.87% | EPS Growth 5Y | — |
| Revenue Growth 1Y | -37.97% | Gross Margin | 0.24% |
| Operating Margin | 0.05% | Profit Margin | 0.05% |
| ROE | 0.09% | ROA | 0.07% |
| ROCE | 0.09% | Current Ratio | 2.59 |
| Quick Ratio | 2.29 | Cash Ratio | 0.47 |
| Debt/Equity | 0 | Interest Coverage | — |
| Altman Z Score | 14.84 | Piotroski Score | 4 |
View Alibaba Health Information Technology financial charts →